Aptevo Therapeutics (FRA:AP8) YoY EPS Growth : -156.39% (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Aptevo Therapeutics YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Aptevo Therapeutics's YoY EPS Growth for the quarter that ended in Mar. 2024 was -156.39%.

Aptevo Therapeutics's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was €-9.15.

Aptevo Therapeutics YoY EPS Growth Historical Data

The historical data trend for Aptevo Therapeutics's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptevo Therapeutics YoY EPS Growth Chart

Aptevo Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EPS Growth

Get a 7-Day Free Trial

57.59

65.54

-24.96

127.59

-187.86

Aptevo Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EPS Growth	Get a 7-Day Free Trial															126.21	-121.51	69.08	69.00	-156.39

Aptevo Therapeutics YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Aptevo Therapeutics's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EPS Growth (A: Dec. 2023 )
=	(Earnings per Share (Diluted) (A: Dec. 2023 )	-	Earnings per Share (Diluted) (A: Dec. 2022 ))	/	\| Earnings per Share (Diluted) (A: Dec. 2022 ) \|
=	(-57.294	-	65.212)	/	\| 65.212 \|
=	-187.86 %

Aptevo Therapeutics's YoY EPS Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EPS Growth (Q: Mar. 2024 )
=	(Earnings per Share (Diluted) (Q: Mar. 2024 )	-	Earnings per Share (Diluted) (Q: Mar. 2023 ))	/	\| Earnings per Share (Diluted) (Q: Mar. 2023 )) \|
=	(-9.154	-	16.233)	/	\| 16.233 \|
=	-156.39 %

Aptevo Therapeutics YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Aptevo Therapeutics's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptevo Therapeutics (FRA:AP8) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptevo Therapeutics Inc (FRA:AP8) » Definitions » YoY EPS Growth

Comparable Companies

Traded in Other Exchanges

APVO:USA

Address

2401 4th Avenue, Suite 1050, Seattle, WA, USA, 98121

Website

https://www.aptevotherapeutics.com

Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

Aptevo Therapeutics (FRA:AP8) Headlines

No Headlines